Cleavage of an inaccessible site by the maxizyme with two independent binding arms: An alternative approach to the recruitment of RNA helicases

Journal of Biochemistry

Volumn 132, Issue 1, 2002, Pages 149-155

  Kuwabara, Tomoko ^a   Warashina, Masaki ^a   Taira, Kazunari ^a,b  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

HIV 1 TAR; Maxizymes; Ribozymes; Substrate binding

Indexed keywords

LUCIFERASE; MESSENGER RNA; RIBOZYME; RNA HELICASE; VIRUS RNA;

ARTICLE; BINDING SITE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; ENZYME SPECIFICITY; GENETICS; HELA CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; KINETICS; LONG TERMINAL REPEAT; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; TIME; DIMERIZATION; ENTROPY; ENZYME BINDING; ENZYME SUBSTRATE COMPLEX; HUMAN CELL;

BASE SEQUENCE; BINDING SITES; CATALYSIS; HELA CELLS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; KINETICS; LUCIFERASES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; RNA HELICASES; RNA, CATALYTIC; RNA, MESSENGER; RNA, VIRAL; SUBSTRATE SPECIFICITY; TIME FACTORS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0036330108     PISSN: 0021924X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jbchem.a003193     Document Type: Article

References (65)

1. A small catalytic oligoribonucleotide
2. Simple RNA enzymes with new and highly specific endoribonuclease activities
3. Self-cleavage of RNA in the replication of small pathogens of plants and animals
4. Kinetic evidence based on solvent isotope effects for the nonexistence of a proton-transfer process in reactions catalyzed by a hammer-head ribozyme: Implication to the double-metal-ion mechanism of catalysis
5. Hammerhead minizymes with high cleavage activity: A dimeric structure as the active conformation of minizymes
6. Evidence for the rate-limiting departure of the 5′-oxygen in nonenzymatic and hammerhead ribozyme-catalyzed reactions
7. 2+ ion with the pro-R oxygen of the scissile phosphate in the transition state of a hammerhead ribozyme-catalyzed reaction
8. The structure, function and application of the hammerhead ribozyme
9. Mechanism of ribozyme-mediated cleavage
10. The hydrolysis of RNA: From theoretical calculations to the hammerhead ribozyme-mediated cleavage of RNA
11. Structure, folding and catalysis of the small nucleolytic ribozymes
12. Identification of the hammerhead ribozyme metal ion binding site responsible for rescue of the deleterious effect of a cleavage site phosphorothioate
13. A further investigation and reappraisal of the thio effect in the cleavage reaction catalyzed by a hammerhead ribozyme
14. Differences among mechanisms of ribozyme-catalyzed reactions
15. Recent advances in the elucidation of the mechanisms of action of ribozymes
16. RNA enzymes (ribozymes) as antiviral therapeutic agents
17. Ribozymes as potential anti-HIV-1 therapeutic agents
18. Controlled, targeted, intracellular expression of ribozymes: Progress and problems
19. Nucleic acids and molecular biology
20. Methods in molecular biology
21. Distinct roles of the coactivators p300 and CBP in retinoic-acid-induced F9-cell differentiation
22. Therapeutic applications of ribozymes: Methods
23. Factors governing the activity in vivo of ribozymes transcribed by RNA polymerase III
24. RNA-protein hybrid ribozymes that efficiently cleave any mRNA independently of the structure of the target RNA
25. Relationships between the activities in vitro and in vivo of various kinds of ribozyme and their intracellular localization in mammalian cells
26. Allosterically controllable ribozymes with biosensor functions
27. Allosterically controllable maxizymes cleave mRNA with high efficiency and specificity
28. Working at the cutting edge: The creation of allosteric ribozymes
29. Characterization of several kinds of dimer minizyme: Simultaneous cleavage at two sites in HIV-1 tat mRNA by dimer minizymes
30. Formation of a catalytically active dimer by tRNAVal-driven short ribozymes
31. A novel allosterically trans-activated ribozyme, the maxizyme, with exceptional specificity in vitro and in vivo
32. Specificity of novel allosterically trans- and cisactivated connected maxizymes that are designed to suppress BCR-ABL expression
33. tRNAVal-heterodimeric maxizymes with high potential as geneinactivating agents: Simultaneous cleavage at two sites in HIV-1 Tat mRNA in cultured cells
34. CTAB-mediated enrichment for active forms of novel dimeric maxizymes
35. Effects of cetyltrimethylammonium bromide on reactions catalyzed by maxizymes, a novel class of metalloenzymes
36. Maxizymes, novel allosterically controllable ribozymes, can be designed to cleave various substrates
37. Oncogene inactivation in a mouse model
38. Chemical and enzymatic probing of effector-mediated changes in the conformation of a maxizyme
39. Allosterically controlled single-chained maxizymes with extremely high and specific activity
40. Human RNA helicase A is homologous to the maleless protein of Drosophila
41. The DEAH-box protein PRP22 is an ATPase that mediates ATP-dependent mRNA release from the spliceosome and unwinds RNA duplexes
42. Unwinding RNA in Saccharomyces cerevisiae: DEAD-box proteins and related families
43. The DExH protein NPH-II is a processive and directional motor for unwinding RNA
44. A cellular cofactor for the constitutive transport element of type D retrovirus
45. TAP, the human homolog of Mex67p, mediates CTE-dependent RNA export from the nucleus
46. TAP binds to the constitutive transport element (CTE) through a novel RNA-binding motif that is sufficient to promote CTE-dependent RNA export from the nucleus
47. Rat8p/Dbp5p is a shuttling transport factor that interacts with Rat7p/Nup159p and Gle1p and suppresses the mRNA export defect of xpol-1 cells
48. The human Tap protein is a nuclear mRNA export factor that contains novel RNA-binding and nucleocytoplasmic transport sequences
49. A role for RNA helicase A in post-transcriptional regulation of HIV type 1
50. Dbp5, a DEAD-box protein required for mRNA export, is recruited to the cytoplasmic fibrils of nuclear pore complex via a conserved interaction with CAN/Nup159p
51. A simple assay system for examination of the inhibitory potential in vivo of decoy RNAs, ribozymes and other drugs by measuring the Tat-mediated transcription of a fusion gene composed of the long terminal repeat of HIV-1 and a gene for luciferase
52. SR alpha promoter: An efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat
53. Rapid renaturation of complementary DNA strands mediated by cationic detergents: A role for high-probability binding domains in enhancing the kinetics of molecular assembly processes
54. Design and specificity of hammer-head ribozymes against calretinin mRNA
55. Inhibition of HIV-1 replication by ribozymes that show poor activity in vitro
56. Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA
57. Kinetic selectivity of complementary nucleic acids: bcr-abl-directed antisense RNA and ribozymes
58. Enhancement of hammer-head ribozyme catalysis by glyceraldehyde-3-phosphate dehydrogenase
59. Identification of genes that function in the TNF-α-mediated apoptotic pathway using randomized hybrid ribozyme libraries
60. Identification of genes by hybrid ribozymes that couple cleavage activity with the unwinding activity of an endogeneous RNA helicase
61. Enhancement in the cleavage activity of a hammerhead ribozyme by cationic comb-type polymers and an RNA helicases in vitro